We performed a scientometric analysis of the scientific literature on ADHD to evaluate key
themes and trends over the past decades, informing future lines of research. We conducted …

This meta-analysis investigated the effects of computerized cognitive training (CCT) on
clinical, neuropsychological and academic outcomes in individuals with attention …

Importance Use of attention-deficit/hyperactivity disorder (ADHD) medications has increased
substantially over the past decades. However, the potential risk of cardiovascular disease …

The COVID-19 pandemic (including lockdown) is likely to have had profound but diverse
implications for mental health and well-being, yet little is known about individual …

Importance Attention-deficit/hyperactivity disorder (ADHD) is associated with increased risks
of adverse health outcomes including premature death, but it is unclear whether ADHD …

Accumulating evidence suggests a higher risk for cardiovascular diseases among
individuals with mental disorders, but very little is known about the risk for overall and …

Despite a growing literature on the complex bidirectional relationship of ADHD and
substance use, reviews specifically focusing on alcohol are scarce. ADHD and AUD show a …

Rationale Psychostimulants, including methylphenidate (MPH), are the mainstay of
pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults. Even though …

Importance Evidence that adult attention-deficit/hyperactivity disorder (ADHD) is associated
with an increased risk of dementia is scarce and inconsistent, and potential sources of bias …

Atomoxetine, a selective norepinephrine (NE) reuptake inhibitor, was approved for attention
deficit/hyperactivity disorder (ADHD) treatment in children, adolescents and adults. We …